Our Cases

I-MAK attorneys have been active in mapping the IP landscape for essential medicines and challenging non-meritorious patents on selected drugs. In India, for example, any person can oppose the granting of a patent prior to its grant/rejection. In selected cases where we feel the patents do not comply with the law, we provide technical analysis and legal support. Here are examples of our cases:

FAQs about our cases

Sofosbuvir (Sovaldi) (HCV)

Lopinavir/Ritonavir (Kaletra/Aluvia/Norvir)(HIV)

Abacavir Sulfate (Ziagen) (HIV)

Nevirapine Hemihydrate (HIV)

Oseltamivir (Tamiflu)(Avian Flu)

Tenofovir Disoproxil Fumarate (Viread)(HIV)